F
1.65
0.21 (14.38%)
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 混合的 | 看涨 |
| Biotechnology (全球的) | 混合的 | 看涨 | |
| 股票 | FibroBiologics, Inc. | 混合的 | 看跌 |
AIStockmoo 评分
0.4
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | -2.0 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 2.0 |
| 平均 | 0.36 |
|
FibroBiologics Inc is a clinical-stage cell therapy company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with significant unmet medical needs, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, and potential extension of life applications including thymic and splenic involution reversal. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 内部持股比例 | 21.42% |
| 机构持股比例 | 16.75% |
所有权
| 姓名 | 日期 | 持有股份 |
|---|---|---|
| Cascade Financial Partners, Llc | 30 Jun 2026 | 108,828 |
| Fund Evaluation Group, Llc | 30 Jun 2026 | 51,794 |
| Islay Capital Management, Llc | 30 Jun 2026 | 169 |
| Grove Bank & Trust | 30 Jun 2026 | 100 |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合